Current Drug Therapy

Dr. Manuela Gaspar has completed her PhD in 2005 in Pharmaceutical Technology in the University of Lisbon and from 2007 to 2008 has done post-doctoral studies in the university of Dublin, Trinity College. She is a researcher in Research Institute for Medicines, iMed. ULisboa, University of Lisbon. The area of research has been focused on the designed, development and biological evaluation of drug delivery systems for improving the therapeutic index of incorporated molecules in infectious, inflammatory and cancer animals model. She is co-author of numerous papers in peer reviewed journals, book chapter and patents.

Dr. Marco Orsini did Graduation in Medicine from Federal University of Rio de Janeiro, UFRJ, Rio de Janeiro, Brazil. Later, he obtained his Masters in Public Health degree from the Federal University of Rio de Janeiro, UFRJ, Rio de Janeiro, Brazil and Doctor of Medicine (Neurology) degree from Fluminense Federal University, UFF, Niterói, Brazil. Dr. Orsini has numerous scientific research and journal article publications to his credit.

Dr. Khalid Aftab, Ph.D. male, Pharmacologist, graduated from department of Pharmacology, Faculty of Pharmacy University of Karachi, Pakistan in 1995. He worked for Pharmaceuticals industry as Quality Control & Quality Assurance professional and was actively involved in Research & Development of Pharmaceutical preparations. He is the Only Pakistani Pharmacologist who has got membership of American College of Clinical Pharmacology. He has published more than 50 papers in scientific journals of international repute and presented many lectures & poster presentations throughout the world. In recent year, he focused on the Biodiversity & Pharmacological activities of Marine organisms and got some important success.

Prof. Israel Amirav is a pediatric pulmonologist and internationally renowned leader in aerosol therapy for infants and young children. He graduated from the Tel Aviv University Medical School in 1981 and then from he undertook a Pediatric Pulmonary fellowship at Children’s Hospital of Philadelphia. After completing his training in the USA, he returned to Israel where he headed the pediatric pulmonology service in the Northern part of Israel for next 25 years. In 2013, he moved to the University of Alberta in Edmonton, Canada where he is currently Associate Professor and Educational Program Director. He has published >90 studies, mainly related to aerosol therapy and also in areas such as asthma and PCD.

Prof. Stefano Angioni is an Associate Professor of Gynecology and Obstetrics at the University of Cagliari, Italy. He obtained a Doctorate (Ph.D.) in Biology of Human and Animal Reproduction from the University of Bari (Italy) and is mainly involved in the surgical and pharmacological management of chronic pelvic pain and infertility. He is the President of the University School of Midwifery at the University of Cagliari. Prof. Angioni authored more than 150 manuscripts and co-edited several scientific books.

Dr. Toshiharu Azma is the Division Director of Perioperative Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Japan. He also serves as the head of the Department of Anesthesiology & Pain Medicine in the hospital. Previously, he served as the associate professor of the Faculty of Medicine, Saitama Medical University, and is currently the visiting associate professor of the University Hospital. During his career at Hiroshima University, he obtained Ph.D. of medicine from the Graduate School of Medical and Pharmaceutical Sciences in 1996. His research interests include: interventional pain medicine, perioperative management and diagnosis for hemostasis, etc.

Prof. Maciej Banach was an Undersecretary of State at the Ministry of Science and Higher Education of the Republic of Poland (2010-2012). He is a President of Polish Mother's Memorial Hospital - Research Institute, full Professor of Cardiology and Head of Department of Hypertension at the Medical University of Lodz, Poland. He is member of the Executive Committee of European Atherosclerosis Society (EAS), Founder and Head of the Polish Lipid Association (PoLA), and the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. He is a Visiting Professor of University of Alabama at Birmingham (UAB) and University of Medicine and Pharmacy Victor Babes in Timisoara, Romania.

Dr. Francesco Bifari obtained his Ph.D. degree (2009) from the Graduate School of Translational Biomedicine, University of Verona, Verona, Italy. Since March 2016, Dr. Bifari has been serving as a Principal Investigator in the Laboratory of Cell Metabolism and Regenerative Medicine, Department of Medical Biotechnology and Translational Medicine, at University of Milan, Milan, Italy. His research interests are focused on understanding the role of newly discovered meningeal-resident adult neural stem cells in brain plasticity and regenerative medicine. Dr. Bifari, as an author/co-author, has published more than 30 articles in various journals, having over 1,530 total citations.

Dr. Francesco Borgia is an Assistant Professor of Dermatology and Venereology at the University of Messina (Italy). His research interests include photodermatology, with particular attention to photodynamic therapy in Non Melanoma Skin Cancer and inflammatory diseases, and drug-related skin adverse reactions. He is the author of more than 60 scientific publications in international journals and chapters in books in the field of dermatology and general medicine.

Dr. Klemens Budde currently works at the Department of Nephrology, Charité Universitätsmedizin Berlin. Klemens does research in Clinical Kidney Transplantation, Immunosuppression, Nephrology, Rare Kidney Diseases, Tuberous Sclerosis Complex (TSC), Databases, and Artificial Intelligence. He has contributed his publication in different scientific journals.

Dr. Cui obtained a doctorate (Ph.D.) in Molecular Immunological Pharmacology from Peking Union Medical College. He has nearly 15 years of experience in the research, drug discovery development of medications aimed to treat cancer, cardiovascular, fibrotic diseases. Currently Dr. Cui is a professor in the Institute Materia Medica, Peking Union Medical College. He has published more than 30 scientific publications and is a named inventor of 8 issued patents.

Dr. Dai obtained his Ph.D degree in Peking Union Medical College in China. He is now an assistant professor in Department of Radiation Oncology at University of Florida. Dr. Dai have been working in the field of cancer biology, radiation therapy and experimental therapeutics for over 17 years. His research is about understanding cancer progression and evaluating therapeutic effects of novel molecular targeting agents. Dr. Dai has accomplished many peer-reviewed publications, including research articles, reviews, book chapters and patents. He also serves as an ad hoc reviewer for over 20 international journals in biomedical science.

Dr. Domenico De Berardis, M.D., Ph.D., works as Psychiatrist and Psychotherapist in the "real world" clinical practice at the NHS Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital “G. Mazzini”, ASL 4 Teramo, Italy. Dr. De Berardis collaborates independently with the Institute of Psychiatry of University of Chieti-Pescara, Italy (concerning research projects and teaching). His research interests and fields of expertise include the following: clinical psychiatry, clinical psychopharmacology, clozapine, newer antidepressants, long-acting antipsychotics, alexithymia, emotions, functional somatic symptoms, anxiety disorders, mood disorders, schizophrenia, functional magnetic resonance, obsessive-compulsive disorder, etc. He has published over 120 peer-reviewed articles, and several book chapters.

Dr. Ding is an Associate Professor with tenure at the Department of Pathology, and a Member of the Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center. He obtained his PhD in Medical Sciences from Lund University, Sweden, and trained as a postdoctoral fellow at the Molecular Pharmacology section, Mayo Clinic and Foundation, Rochester Minnesota. Dr. Ding has been actively engaged in exploring drug action mechanisms over the last 20 years, with effort concentrated on anticancer actions of n-3 polyunsaturated fatty acids and metal binding compounds.

Dr. Serdar Durdagi is presently serving as an Associate Professor in Bahcesehir University (BAU), School of Medicine. Dr. Durdagi completed PhD in 2009 and his research interests include HIV-1 protease and its inhibitors, C60 (Fullerene) and Its Derivatives for Different Biological Applications, Carbonic Anhydrase (CA) enzymes and their inhibitors, Nanoporous structures and Nanoporous structures. He is a member of Biophysical Society, Canadian Society for Chemistry, American Chemical Society and Molecular Graphics and Modeling Society. He has contributed multiple publications in different scientific journals.

Dr. Hanaa S. El-Desoky is presently working as a Full Professor of Analytical Chemistry at Tanta University, Faculty of Science, Egypt. She has been involved in an analytical chemistry projects (as Vice-Principal Investigator) related to electro analytical chemistry techniques on drug active compounds and DNA–Drug interactions "Preparation and characterization of some Nano materials and its electrochemical applications as sensors for trace determination of some pharmaceutical compounds in its formulations and biological fluids". Her research interests include analysis of pharmaceuticals using different analytical techniques and different voltammetric sensors modified with nanomaterial. She is the Editorial Board Member of "SF Journal of Pharmaceutical and Analytical Chemistry". She got "International Publication Award" from Tanta University for 30 scientific publications in international Journals.

Dr. N. Gadoth Obtained a doctorate (MD) from the Hebrew University, Hadassah School of Medicine, Jerusalem, Israel. He trained both in Israel and the John's Hopkins Hospital, Baltimore, USA, in Pediatric and adults neurology. He is the former chairman of the section of Neurology and Neurosurgery at the Tel-Aviv University, Israeli Society of Pediatric Neurology and Israeli Neurological Association. He is presently serving as the Chairman of Israeli neurophysiological society and the emeritus professor (at the Tel-Aviv University). He is also a member of more than 20 international scientific societies, 5 editorial Boards and senior/ associated author of more than 200 peer-review publications, 6 book chapters and 1 book editor.

Dr. R. Jayakumar is a Professor at the Centre for Nanosciences and Molecular Medicine (ACNSMM), Amrita Vishwa Vidyapeetham, specializing in the area of Biomaterials for Healthcare Applications. Dr. R. Jayakumar joined ACNSMM in November 2007. He received his Ph.D. in Polymer Chemistry from Anna University, Chennai, India (2002). Dr. Jayakumar's research laboratory at ACNSMM focuses on development of biodegradable polymeric nanofibers, nanogels, nanoparticles, nanocomposite scaffolds and injectable hydrogels for Tissue Engineering, Drug Delivery, and Wound Dressing applications.

Professor Roya Kelishadi is a specialist in Pediatrics, working as a faculty member of Isfahan University of Medical Sciences in Iran. Over her 20-year career, she focused on primordial/primary prevention of non-communicable diseases. She is the founder and chair of the Research Institute for Primary Prevention of Non-communicable Disease, as well as the founder and chair of the Child Growth and Development Research Center affiliated to Isfahan University of Medical Sciences. She is also the founder and Editor-in-Chief of the International Journal of Preventive Medicine. Her studies are focused on lifestyle and environmental factors related to the early life origins of adult chronic diseases.

Dr. Varun Khurana graduated with a Ph.D. in Pharmaceutical Sciences and Chemistry from reputed University of Missouri Kansas City, Kansas City, MO. Currently, he is working as a Formulation Scientist at Nevakar LLC, Bridgewater, NJ, a specialty pharmaceutical company that develops and commercializes innovative products in injectable and ophthalmic space. Prior to Nevakar, he was employed as a Formulation Scientist at Insys Therapeutics Inc, Chandler, AZ. His research has been published in several peer-reviewed journals and books in the field of pharmaceutical sciences.

Dr. Aleksandra Kładna is the Professor of Pomeranian Medical University in Szczecin. She obtained Ph.D. of medicine in 1986 and Habilitation in 1996. She is a medical specialist in Dermatology with Venerology and in Palliative medicine. She has over 30 years of experience of being a lecturer, a clinicist and a researcher. She is a member of many scientific societies. Her research interests include: the role of oxygen free radical in human diseases and the usage of novel compounds antioxidant properties, public health, medical empathy. She is also an author/co-author of 138 scientific publications and one book.

Dr. Menaa (PhD, MBA, MD candidate) is an internationally inter- and multi-disciplinary professional with holistic concept of Medicine. More than 10 years experiences in academic institutions (e.g. France, USA, Germany, Brazil) and industrial sectors (e.g. Guerbet SA, SANOFI, Fluorotronics Inc.). He is an independent consulting expert, researcher and Chief Editor of Journal of Nano medicine and Nanotechnology. He is also member of various scientific committees, boards and associations, and organized the “Target Meeting´s 1st World Nano medicine and Nano biotechnology Online Conference. He has contributed to over 100 scientific articles, 200 international events, and is the recipient of various recognitions.

Prof. (Dr.) Pradyumna Mishra is currently Deputy Director of the ICMR-National Institute for Research in Environmental Health, Bhopal, India. He is a recipient of prestigious Fulbright-Nehru Fellowship (USA) and is a Visiting Faculty Associate to Weizmann Institute of Science, Israel and Osaka University, Japan. Recently, he was nominated as one of the Foreign Affiliate Members in Foundation for Polish Science, Warsaw, Poland. He is Associate Editor-in-Chief of Frontiers in Genetics and serves on the editorial boards of several scientific journals and committees as well as technical advisory bodies. He is primarily involved in inter-disciplinary research with equal emphasis laid on molecular immunology and translational medicine. Dr. Mishra’s track record of academic accomplishments is backed up by more than 125 primary peer-reviewed publications (Citations>2400; Impact Factor>335.0; h-index=30). He has several collaborative research projects with leading academic investigators in established centres of excellence both in India and abroad.

Dr. Monica Mita is a medical oncologist in Los Angeles, California and is affiliated with multiple hospitals in the region, including Cedars-Sinai Medical Center and UCLA Medical Center Santa Monica. She received her medical degree from Carol Davila University of Medicine and Pharmacy and has been in practice for more than 20 years. She is currently co-director of the Experimental Therapeutics Program at the Samuel Oschin Comprehensive Cancer Institute. Her main research are on phase I clinical trials in oncology, novel drugs, and targeted therapies, with more than 50 peer reviewed articles published.

Dr. Francesco Orio, MD, PhD, is currently affiliated with the Parthenope University of Naples (Naples, Italy), in the Department of Endocrinology. His research interests mainly lie in the subject areas of Ovary Polycystic Disease, Hyperandrogenism, Vitamin D Deficiency, Obesity, etc. Dr. Orio, as an author/co-author, has published more than 185 articles in various reputed journals, having a significant number of total citations, i.e. over 7,700.

Sibel A. Ozkan is presently working as a Full Professor of Analytical Chemistry at Ankara University, Faculty of Pharmacy. She has been involved in several analytical chemistry projects related to electroanalytical chemistry and separation techniques on drug active compounds and DNA–Drug interactions. Her research interests included analysis of pharmaceuticals with using different analytical techniques. She has published more than 200 original and review papers and two scientific books from HNB Publishing, (2012) and Springer (2015). She is the Editor and Editorial Board Member of the many journals.

Dr. Arulselvan Palanisamy is presently serving as Adjunct Associate Professor, Muthayammal Centre for Advanced Research (MCAR), Muthayammal College of Arts and Science, Tamil Nadu, India. His research interests include Diabetes and diabetic wound healing, Nanomedicine for cancer therapy (Drug delivery system), Inflammation and Cancer Biology and Natural Products Research for inflammation, diabetes and cancer. He has contributed his publications in different scientific journals.

Dr. Paliwal received his doctorate from Dr. H. S. Gour University, Sagar, India. Presently, he is working in the Department of Pharmacy, Indira Gandhi National Tribal University, Amrkantak, India. He has nearly 12 year of research experience in nanomedicine, controlled drug delivery and cancer drug targeting. He has contributed as author/co-author in 35 international publications, 14 book chapters, 2 guest edited issues and 01 book. Dr. Paliwal is recipient of many national and international awards including MP young scientist award 2007, Rudolf Cimdins award 2009 and career award for young pharmacy teachers, 2013 to his credit. Additionally, he is an active reviewer of more than 30 international journals and grant funding agencies.

Dr. Carolina Panis, MD, PhD (in biochemistry), post-graduated in Pathology from the Londrina State University (UEL), Brazil, and Instituto Nacional do Câncer (INCA), Brazil. Dr. Panis currently works as a professor and researcher at the State University of West Paraná (UNIOESTE), Brazil, in projects related to genomics, proteomics and inflammatory aspects of human breast cancer and chronic diseases. Dr. Panis, as an author/co-author, has published more than 70 articles in various journals, having over 935 total citations.

Dr. Deepa Patel is enthusiastic academician and an active researcher in field of Pharmaceutical Technology (GATE qualified). Her research interests primarily focus on developing and translating new drug delivery systems for the prevention and treatment various diseases such as Cancer, HIV and Asthma.. She has published 15 research papers in high Impact factor journals. She has filed 04 Indian patent applications in field of Novel Drug Delivery Systems and published 03 International book chapters and edited one book at international level to her credit.. She presented her research paper in 06 international conferences (organized in USA and Canada). She has guided 33 post-graduate students and currently guiding 6 Ph.D students. Currently, she is working as an Associate Professor in Pharmaceutics Department, Faculty of Pharmacy, Parul University. She has 8 h-index and 373 citations in scopus and 8 h-index and 439 citations in Google Scholar, 6 h-idex and 224 citations in Web of science.

He is an Assistant Professor in Pharmaceutical Chemistry and Technology at the Department of Pharmacy, University of Salerno. He holds a degree in Chemistry from the Faculty of Chemistry at the University “Federico II” of Naples, in 1997, vote 110/110 cum laude. He did PhD in Chemistry in 2002 from the University “Federico II” of Naples From 2002 to 2004, he worked as scientific manager and researcher at the "Laboratory of bio-analytical mass spectrometry " to the Interdepartmental Biotechnology Research Centre at the University of Bologna. From 2004 to 2006, he worked as young researcher at DiFarma to lead a project on metabolomics and proteomics of Salvia ssp plants. In 2000, he worked at the International Agency for Research on Cancer (IARC) of Lion (France) with Dr. Marlin Friesen, to develop new methods to identify DNA polymorphisms by mass spectrometry.

Dr. Pomara is the Director of the Geriatric Psychiatry Division at Nathan S. Kline Institute (NKI) and a Professor in the Department of Psychiatry and Pathology at the New York University School of Medicine. He has been involved in research pertaining to Alzheimer’s disease and Geriatric Psychopharmacology for more than 30 years. Dr. Pomara has more than 140 authored publications, 15 chapters/books, and 80 collaborative publications. He has received numerous grants from the NIH and presented at various national and international scientific meetings. He is a member of both the American and European College of Neuropsychopharmacology in addition to many other scientific organizations.

Dr. Arun Ravindran is Full Professor and Director of Global Mental Health and the Office of Fellowship Training for the Department of Psychiatry, University of Toronto. He is cross-appointed as Graduate Faculty in the Institute of Medical Sciences, and is also a Senior Scientist in the Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health. Dr. Ravindran’s clinical and research interest is in the area of mood and anxiety disorders. He has held or currently holds grant funding from national and international agencies. He is also actively involved in capacity-building and humanitarian global mental health projects .

Dr. Catarina Pinto Reis is presently serving as Assistant Professor at the Faculty of Pharmacy of University of Lisbon. Her research interests include Development of new drug delivery systems, Theranostics, Therapeutic polymers for drug delivery, Methods of micro and nanoencapsulation of drugs, food supplements and cosmetics, Drug dissolution, absorption, metabolism and elimination studies, Targeted therapies, in vivo efficacy and safety assessments using animal models, Pre-clinical toxicity assessment, Food supplements, Regulatory affairs, Medical Devices, cosmetics, etc. She has contributed her publications in different scientific journals.

Dr. Bechan Sharma is presently working as a Professor, Biochemistry Department, Allahabad University, India. His interest includes Molecular Biology, Tropical Diseases and Biochemical Toxicology. With 30 years of teaching / research experience, he has received number of Awards and Honors. He has published over 170 research papers, 4 books and one US patent. He has supervised 15 PhDs and 5 PDFs. He is a Editorial Board /Reviewer member for 130 International journals. He has widely visited to USA and other European labs. He is currently involved in a multinational research project with Koyoto University-Japan on anti HIV-1Drug design and development.

Dr. Emmanuel A. Theodorakis obtained Ph.D. from Texas A & M University. He has been serving as a Professor of Chemistry and Teddy G. Traylor Scholar at University of California, San Diego. His skills and expertise are in Synthesis, Organic Synthesis, Synthetic Organic Chemistry, Medicinal and Pharmaceutical Chemistry, Natural Product Chemistry, Multistep Synthesis, Drug Synthesis and Synthetic Methodology. He has contributed more than 180 publications, having citations around 5,467. He has also been recognized with awards and honors such as Teddy G. Traylor Scholar Award, UCSD, Hellman Faculty Fellowship Award, Editorial board member: Current Chemical Biology and etc.

Chun-Wei Tung is an Associate professor in Graduate Institute of Data Science, Taipei Medical University, Taiwan. He is also an adjunct assistant research fellow in National Environmental Health Research Center, NHRI, Taiwan. His research interests include bioinformatics, immunoinformatics and toxicoinformatics. He is also a member of IAPR TC-20 (Technical Committee on Pattern Recognition in Bioinformatics).

Bengi USLU is currently a Professor in Ankara University in the Faculty of Pharmacy, Department of Analytical Chemistry, in Turkey. Her areas of interest are electrochemistry, biosensors, nanosensors biotechnology, liquid chromatography, drug analysis, biological sample analysis, redox mechanisms of drugs, spectrophotometry, validation, separation techniques, method development, research and development. She has published as author or co-author of more than 150 scientific articles and publications. In 2008, she received Ankara University Scientific Support Award, in 2014, she received Ankara University Scientific Award and in 2015, she received Academy of Pharmacy Science Award of Turkish Pharmaceutical Association. She has been co-editor of special issues and reviewer of many scientific journals. She has a number of chapters published in books and has also translated books.

Dr. Bruno Vincenzi is presently serving as an Associate Professor at Campus Bio-Medico University Rome, Italy. He has completed his PhD and contributed his valuable publications in different scientific journals.

Dr Vree worked as chemist, pharmacologist and faculty member in the departments of Clinical Pharmacy (laboratory) and Anesthesiology of the Radboud University, Nijmegen, The Netherlands. Dr. Vree has authored and co-authored 600 publications dealing with the chemical analysis of drugs and its metabolites in body samples of patients of a wide variety of medical disciplines in the University Hospital. Research activities included chemical analysis of drugs, metabolites and conjugates, pharmacokinetics and bioequivalency.

Dr. Fan Wang obtained her Ph.D. from China Institute of Atomic Energy, Beijing, China. She is currently a full professor and director of Medical Isotopes Research Center, Peking University, China. She has published more than 80 scientific publications and is a named inventor of 8 issued Chinese patents. Dr. Wang serves as the Associate Editor of Biophysics Reports, editorial board member of Bioconjugate Chemistry and Nuclear Science & Techniques.

Dr. Avi A Weinbroum is presently associated with the Ministry of Health, Israel and serves as a Professor at the department of Anaesthesiology and Critical Care Medicine Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Dr. Weinbroum's research interests include Pain Management, Anesthesia, Chronic Pain, Anaesthetics, Acute Pain, General Anesthesia, Hemodynamics, Pain Medicine and Laparotomy. Dr. Weinbroum has contributed multiple publications in different scientific journals.

Jeffrey Weitz is Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University, Canada and Executive Director of the Thrombosis and Atherosclerosis Research Institute in Hamilton, Canada. He holds the Canada Research Chair in Thrombosis and the Heart and Stroke Foundation J. Fraser Mustard Chair in Cardiovascular Research. His clinical practice focuses on patients with thrombosis and his research spans the spectrum of basic, translational and clinical investigation into the pathogenesis, diagnosis and treatment of thrombotic disorders. He has published over 450 peer-reviewed papers and 60 book chapters on thrombosis and fibrinolysis.

Dr. Wexler is a senior pharmaceutical professional with a successful track record of driving global company initiatives from conception to implementation through leadership and collaboration with increasing responsibility from analyst to senior manager. He has experience of managing portfolios, working with vendors, and leading function planning activities. He has extensive experience working across a variety of technical areas including designing Phase I clinical trials, performing pharmacokinetic/pharmacodynamics analysis, developing SOPs and training, writing clinical pharmacology sections of clinical reports and submission documents. He has trong strategic thinking and contingency planning skills that delivers a bottom line impact aligned with business objectives.

Dr. Dharmendra Kumar Yadav obtained a Ph.D. in Biomedical Sciences from CSIR- Central Institute of Medicinal and Aromatic Plants, Lucknow, India in 2013. Currently, he is working as a Research Professor and Principal Investigator of NRF project (Korea) at College of Pharmacy at Gachon University, Korea. His research interests included Molecular modeling & Drug Design, and Molecular simulation of Plasma Medicine. He has published more than 45 original and review papers and three scientific books chapter one US patent. He is the Editor and Editorial Board Member of the many journals.

Dr. Zanarini is currently principal investigator of the McLean Study of Adult Development or MSAD—an NIMH-funded study of the long-term course of BPD now entering its 24th year. She is also the principal investigator of an NIMH-funded, internet-based randomized controlled trial of an early form of treatment for BPD: psych education. Her research focuses on Borderline personality disorder (BPD) involves maladaptive symptoms or traits in affect, cognition, behavior, and interpersonal relationships

Dr. Yanmin Zhang is a full professor of School of Pharmacy, Health Science Center, Xi'an Jiaotong University of China. Yanmin Zhang received his B.S. in chemistry and Ph.D. in Pharmacy. He is currently the director of molecular pharmacology program. He has more than 15 national projects, published 117 papers including Pharmacol Therapeut, Advanced Science, Semin Cancer Bio, Cell Death Dis, Sci Rep, J Cell Mol Med, Cancer Lett, et al. and has 26 patents to his credit.

Dr. F. Şen is an Associate Professor of Inorganic and Nano Chemistry at the Dumlupinar University, Turkey. He completed his PhD from Middle East Technical University (METU). In 2011, he spent almost two years at Massachusetts Institute and Technology (MIT) – USA as a Post-doc in the research group of Prof. M. S. Strano involving with different nanomaterial and their applications such as biosensors, biofuel cells, thermo power energy generation, carbon nanotubes, graphene etc. He has published over 80 international publications in scientific journals published within the scope of SCI, almost 2000 citations to these publications. He has got many popular research incentive awards.

Dr. Guozhen Cui is presently serving as a Research fellow in pharmacology Lab, Institute of Chinese Medical Sciences, University of Macau, China. He completed his Master from Institute of Zoonosis (Key Laboratory of Zoonosis of Ministry of Education), Jilin University, China. He further obtained PhD from Institute of Chinese Medical Sciences (The State Key Laboratory of Quality Research in Chinese Medicine), University of Macau, China. His research interest includes Preventative nature agents screening and compound target identification, mainly focuses on mechanistic study in age-related diseases and rich man's disease (disease of the affluent) through the exploration of the mechanism of action of herbal medicines. He has contributed his valuable publications in different scientific journals.

Dr. Firinu obtained full degree in Medicine in 2007. . He has been working at the Department of Internal medicine, Allergy and Clinical Immunology at the Cagliari University, Italy. His research interests include autoimmunity, primary immunodeficiency and rare diseases associated with dysregulation of immunity. In 2013, he has been elected as the Junior Representative in Biological Interest Group, at European Academy of Allergy and Clinical Immunology. Currently, he is an Associate Professor at the University of Cagliari. He has 98 publications to his credit and 1183 citations.

Dr. Hamid Irannejad did his Pharm.D from Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran in 2005. He received his Ph.D. in Medicinal Chemistry from Tehran University of Medical Sciences, Iran in 2010. He also spent one year on research (anti-HIV and anti-cancer compounds) at University of Siena, Italy. Currently, he is working as an Associate Professor of Medicinal Chemistry at Mazandaran University of Medical Sciences, Sari, Iran. His research interests are Synthetic organic chemistry, Molecular Docking, Molecular Dynamic Simulation, 2D and 3D-QSAR and Instrumental analysis (NMR, Mass, HPLC, IR).

Dr Vandita Kakkar is an Assistant Professor in the Department of Pharmaceutics, U.I.P.S, Panjab University, Chandigarh and has a research experience of more than 8 years. Her area of research lies in: Bioavailability enhancement of phytopharmaceuticals using nanoparticle technology via oral and topical routes; Scale up of the nanoparticle production from lab scale to pilot stage; Combatting antimicrobial resistance, & developing targeted delivery systems for cancer treatment. She has to her credit 36 international/national research papers and review articles with h-index 12 and 1006 citations; 6 book chapters in international books and 2 national patent applications.

Dr. Anwar Ullah is a full-time Assistant Professor in Biosciences and working in the area of Biochemistry, structural and Moleculecular Biology. His expertise and research interests are Purification, characterization, and crystallization of proteins from both natural and recombinant sources, Protein crystallography, structure determination, structure base drug discovery, protein-protein and protein-ligand interaction, structure bioinformatics, crystal diffraction, data collection, data processing, and structural solution.

Dr. Wei Wang is an associate professor at Jiangsu Institute of Parasitic Diseases and the Key Laboratory on Technology for Parasitic Disease Prevention and Control, National Health Commission of China. His research interests focus on drug development and screening for neglected tropical diseases (NTDs) and drug resistance. Dr. Wei Wang has published over 100 scientific papers in international peer-reviewed journals and book chapters.

Dr. Maria Jesus Alvarez Cubero graduated in Biology and later obtained her PhD. She has been collaborating in teaching and scientific tasks as it is proved with her 48 publications in indexed databases in the forensic genetic, biomedicine and oncology field, most of the half in Q1 standing). She has expertise in research training and teaching which is recognized by national agencies such as ANECA.

Dr. Iain P. Hargreaves is presently serving as a Senior lecturer in biochemistry/clinical biochemistry. Dr. Hargreaves completed PhD in Biochemistry from Liverpool University. Dr. Hargreaves has conducted research in the area of mitochondrial metabolism and coenzyme Q10 biosynthesis/metabolism and multiple researches have been done in different scientific journals.